Recruiting

Enviromedica

Sponsor:

OvationLab

Code:

NCT07355634

Conditions

Gastrointestinal

Eligibility Criteria

Sex: All

Age: 25+

Healthy Volunteers: Not accepted

Interventions

Synbiotic Dietary Supplement

Placebo

Study Details

Brief summary:

A 12-week, randomized, double-blind, placebo-controlled clinical trial will be conducted evaluating the effectiveness of Enviromedica - Terraflora Daily Care on markers of gastrointestinal function and symptoms.

Conditions

Gastrointestinal

Study ID

NCT07355634

Start date

Jan 12, 2026

Status verified date

May, 2026

Completion date

Sep, 2026

Anticipated

Primary completion date

Jun, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 25+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Adult males or females age ≥ 25 years
2. Ability to read and speak English
3. Dysbiosis (≥3 on GA-Map Dysbiosis Score) on a stool test (GI360 Profile, Doctor's Data, St. Charles, Illinois)

Exclusion Criteria:

1. Daily use within the past month of any probiotic or prebiotic supplement
2. Current diagnosis of inflammatory bowel disease, including Crohn's or ulcerative colitis
3. Current daily usage of non-steroidal anti-inflammatory drugs (NSAID), proton pump inhibitors (PPI), or antibiotic medications
4. Current daily tobacco smoker
5. Known allergies to any substance in the study products
6. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks
7. Current diagnosis of any other chronic health condition (e.g., cancer, chronic kidney disease) deemed clinically contraindicated for the study protocol
8. Current participation in another clinical trial
9. Participants unable to provide consent

Study Design

Enrollment

40 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Other

Interventions and Outcome Measures

Arms

experimental: Terraflora - Daily Care

placebo comparator: Placebo

Interventions

Synbiotic Dietary Supplement

12 weeks of supplementation with Enviromedica - Terraflora Daily Care

Placebo

Placebo capsule

Primary outcome measure

  • GA-Map Dysbiosis on GI360 Profile [ Time Frame: 4 weeks, 12 weeks ]

Central Contacts and Locations

Central contacts

Locations

OvationLab

Recruiting

Richmond, Virginia, United States, 23220

Contacts

More Information

Sponsor

OvationLab

Last update posted

May 11, 2026

Last verified

May, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by OvationLab on 2026-05-11.